Is routine ultrasound guidance really necessary for closure of patent foramen ovale using the Amplatzer PFO occluder?

Catheterization and Cardiovascular Interventions

Volumn 73, Issue 3, 2009, Pages 361-366

  Fateh Moghadam, Suzanne ^a   Steeg, Martin ^a   Dietz, Rainer ^a   Bocksch, Wolfgang ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Catheterization; Device closure; Echocardiographic guidance; Patent foramen ovale

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ADULT; ANGIOGRAPHY; ARTICLE; CARDIOVASCULAR EQUIPMENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE THERAPY; EMBOLISM; FEASIBILITY STUDY; FEMALE; FLUOROSCOPY; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; INTRACARDIAC ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATENT FORAMEN OVALE; PATENT FORAMEN OVALE OCCLUDER; PATIENT SAFETY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; VEIN THROMBOSIS;

ECHOCARDIOGRAPHY; FEMALE; FORAMEN OVALE, PATENT; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; PROSTHESIS IMPLANTATION; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 65549165575     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21859     Document Type: Article

References (25)

1. Nendaz MR, Sarasin FP, Junod AF, et al. Preventing stroke recurrence in patients with patent foramen ovale: Antithrombotic therapy, foramen closure or therapeutic abstention. A decision analytic perspective. Am J Heart J 1998;135:532-541.
2. Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: A systematic review. Ann Intern Med 2003;139:753-760.
3. Windecker S, Wahl A, Nedeltchev K, et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004;44: 750-758.
4. Hung J, Landzberg MJ, Jenkins KJ, et al. Closure of patent foramen ovale for paradoxical emboli: Intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol 2000;35:1311-1316.
5. Braun MU, Fassbender D, Schoem SP, et al. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol 2002;39:2019-2025.
6. Alameddine F, Block PC. Transcatheter patent foramen ovale closure for secondary prevention of paradoxical embolic events: Acute results from the FORECAST registry. Catheter Cardiovasc Interv 2004;62:512-516.
7. Braun M, Gliech V, Boscheri A, et al. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems. Eur Heart J 2004;25: 424-430.
8. Kerut EK, Norfleet WT, Plotnick GD, et al. Patent foramen ovale: A review of associated conditions and the impact of phyiological size. J Am Coll Cardiol 2001;38:613-623.
9. Pearson AC, Nagelhout D, Castello R, et al. Atrial septal aneurysm and stroke: A transesophageal echocardiographic study. J Am Coll Cardiol 1991;18:1223-1229.
10. Meier B. Pacman sign during device closure of the patent foramen ovale. Catheter Cardiovasc Interv 2003;60:221-223.
11. Webster MW, Chancellor AM, Smith HJ, et al. Patent foramen ovale in young stroke patients. Lancet 1988;2:11-12.
12. Windecker S, Wahl A, Chatterjee T, et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: Long-term risk of recurrent thromboembolic events. Circulation 2000;101:893-898.
13. Martin F, Sa'nchez PL, Doherty E, et al. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation 2002;106:1121-1126.
14. Khositseth A, Cabalka AK, Sweeney JP, et al. Transcatheter Amplatzer device closure of atrial septal defect and patent foramen ovale in patients with presumed paradoxical embolism. Mayo Clin Proc 2004;79:35-41.
15. Chatterjee T, Petzsch M, Ince H, et al. Interventional closure with Amplatzer PFO occluder of foramen ovale in patients with paradoxical cerebral embolism. J Interv Cardiol 2005;18:173-179.
16. Hong TE, Thaler D, Brorson J, et al. Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the Amplatzer PFO occluder: Initial and intermediate-term results of the U.S. multicenter clinical trial. Catheter Cardiovasc Interv 2003;60:524-528.
17. Ponnuthurai FA, van Gaal WJ, Burchell A, et al. Safety and feasibility of day case patent foramen ovale (PFO) closure facilitated by intracardiac echocardiography. Int J Cardiol 2007; doi:10.1016/ j.ijcard.2007.07.141.
18. Earing MG, Cabalka AK, Seward JB, et al. Intracardiac echocardiographic guidance during transcatheter device closure of atrial septal defect and patent foramen ovale. Mayo Clin Proc 2004; 79:24-34.
19. McMahon CJ, El Said HG, Mullins CE. Use of the transseptal puncture in transcatheter closure of long tunnel-type patent foramen ovale. Heart 2002;E3:88.
20. Meier B. Reply to the letter "Long-term results after PFO closure." Heart 2008;94:100-101.
21. Wahl A, Kunz M, Moschovitis A, et al. Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism. Heart 2008;94:336-341.
22. Varma C, Benson LN, Warr MR, et al. Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance. Catheter Cardiovasc Interv 2004;62: 519-525.
23. Bijl JM, Ruygrok PN, Hornung TS, et al. Percutaneous closure of patent foramen ovale. Intern Med J 2005;35:706-710.
24. Hildick-Smith D, Behan MW, Haworth P, et al. Patent foramen ovale closure without echocardiographic control: Use of "standby" intracardiac ultrasound. J Am Coll Cardiol Intv 2008; 1:387-391.
25. Wahl A, Windecker S, Eberli FR, et al. Percutaneous closure of patent foramen ovale in symptomatic patients. J Interven Cardiol 2001;14:203-209.